Evidence‑Based Guidelines for Persistent Vomiting Evaluation and Management

Diagnosis and Classification

Cyclic vomiting syndrome (CVS) diagnostic criteria – Episodes must be stereotyped, acute‑onset, last < 7 days, occur ≥ 3 times per year (≥ 2 times in the prior 6 months), and be separated by ≥ 1 week of baseline health. 1
Key historical elements for chronic vomiting – Document timing, duration, associated nausea/retching, triggers (e.g., stress, sleep loss, hormonal changes, fasting, intense exercise), medication and substance use (including cannabis). 1
Hot‑water bathing/showering behavior – Reported in ~48 % of CVS patients; it is not pathognomonic for cannabinoid hyperemesis syndrome. 1

Validated severity tools – Use the Pregnancy‑Unique Quantification of Emesis (PUQE) or the HyperEmesis Level Prediction (HELP) score to objectively grade vomiting severity in pregnant patients. 2
Ketonuria is unreliable – Do not rely on urine ketones to assess dehydration severity during pregnancy. 2

Trigger identification and mitigation – Counsel patients to recognize and avoid common precipitants such as stress, sleep deprivation, hormonal fluctuations, fasting, and vigorous exercise. 1

First‑line antiemetics – Initiate H1‑antihistamines, phenothiazines, or the combination of doxylamine + pyridoxine, which have the strongest safety and efficacy data for nausea and vomiting in pregnancy. 2
Second‑line antiemetics –
- Ondansetron is considered safe; the minimal absolute increase in orofacial cleft risk with first‑trimester exposure is outweighed by its benefit in controlling severe vomiting. 2
- Metoclopramide is safe and effective but should be reserved for second‑line use because of extrapyramidal side‑effect risk; administer intravenously as a slow bolus over ≥ 3 minutes. 2
Combination therapy – When a single agent fails, combine antiemetics with different mechanisms of action to enhance efficacy. 2

Intravenous fluid regimen – Provide normal saline (0.9 % NaCl) with added potassium chloride in each bag, titrating based on daily electrolyte monitoring. 2
Thiamine supplementation – Give thiamine 100 mg orally three times daily or intravenously as part of a vitamin B complex to all admitted patients with persistent vomiting or markedly reduced oral intake. 2
Prevent Wernicke’s encephalopathy – Administer thiamine before any dextrose‑containing fluids or parenteral nutrition. 2
Pregnancy termination as a last resort – Exhaust all pharmacologic, hydration, and nutritional strategies—including combination antiemetic therapy and enteral/parenteral nutrition—before considering pregnancy termination. 2

Severity classification –
- Mild CVS: < 4 episodes/year, each < 2 days, no emergency department visits or hospitalizations.
- Moderate‑severe CVS: ≥ 4 episodes/year, each > 2 days, with ≥ 1 emergency department visit or hospitalization. 1
Abortive therapy plan – Develop an individualized rescue medication regimen for patients to use during the prodromal phase of an episode. 1
Address comorbidities – Treat associated conditions such as anxiety, depression, migraine, and postural orthostatic tachycardia syndrome, as this reduces CVS episode frequency and inter‑episodic symptoms. 1
Behavioral considerations – Recognize that self‑induced vomiting or excessive water drinking in CVS are self‑soothing behaviors, not malingering. 1

Offer serial ultrasound examinations to assess fetal growth in patients with persistent vomiting during the third trimester, particularly when total pregnancy weight gain is less than 7 kg, because these patients have a higher risk of preterm birth and low birth weight. 3
Continue anti‑emetic medication after discharge and provide clear instructions for patients on how to obtain further care if vomiting recurs. 3
Arrange re‑hydration and anti‑emetic review in an ambulatory day‑care setting rather than inpatient admission, since roughly one‑third of women are readmitted later in the same pregnancy. 3

Do not rely on ketone testing to make decisions about hydration status or the intensity of anti‑emetic therapy in late‑pregnancy vomiting, as ketonuria is an unreliable marker in this context. 3

Begin with one tablet (10 mg doxylamine + 10 mg pyridoxine) taken at bedtime; if symptoms persist, add a second tablet in the morning (total = 2 tablets/day); if still inadequate, add a third tablet at midday (total = 3 tablets/day); the maximum standard regimen is four tablets daily (one tablet each in the morning and midday, two tablets at bedtime), delivering a total of 40 mg doxylamine and 40 mg pyridoxine per day 4.

When the maximum four‑tablet dose fails to control nausea and vomiting, clinicians should advance to second‑line antiemetics such as ondansetron or metoclopramide, or combine antiemetics with different mechanisms of action, using validated severity tools (e.g., the Pregnancy‑Unique Quantification of Emesis [PUQE] score) to guide treatment decisions 4.